RPT-UPDATE 1-FDA OKs Bayer IUD for heavy menstrual bleeding
(Repeats to additional clients)
NEW YORK Oct 1 (Reuters) - The U.S. Food and Drug Administration has approved Bayer AG's (BAYGn.DE) Mirena intrauterine device to treat heavy menstrual bleeding in IUD users, the company and the agency said on Thursday.
Mirena is already on the market as a contraceptive system. The company will now be allowed to promote it for the new use for women who choose to use IUD contraception to prevent pregnancies.
The product is the first contraceptive approved to treat heavy menstrual bleeding in the United States, Bayer said.
Heavy menstrual bleeding affects between nine and 14 percent of healthy women, according to a gynecologic survey cited by Bayer. (Reporting by Bill Berkrot, editing by Leslie Gevirtz)
- Alabama man gets $1,000 in police settlement, his lawyers get $459,000
- Probe: Athletes took fake classes at University of North Carolina
- Ottawa pushes for business as usual after shootings |
- Man arrested after jumping White House fence, causing lockdown
- U.S.-led air strikes killed 521 fighters, 32 civilians in Syria: monitor